Abreva en es it fr

Abreva Brand names, Abreva Analogs

Abreva Brand Names Mixture

  • No information avaliable

Abreva Chemical_Formula


Abreva RX_link

No information avaliable

Abreva fda sheet

Abreva msds (material safety sheet)

Abreva Synthesis Reference

No information avaliable

Abreva Molecular Weight

312.446 g/mol

Abreva Melting Point

169.5 oC

Abreva H2O Solubility

No information avaliable

Abreva State


Abreva LogP


Abreva Dosage Forms

Tablets for oral administration (10mg)

Abreva Indication

Used to treat irregular duration of cycles and irregular occurrence and duration of periods caused by progesterone deficiency. Also used to prevent natural abortion in patients who have a history of habitual abortions.

Abreva Pharmacology

Dydrogesterone is an orally active progestogen which acts directly on the uterus, producing a complete secretory endometrium in an estrogen-primed uterus. At therapeutic levels, dydrogesterone has no contraceptive effect as it does not inhibit or interfere with ovulation or the corpus luteum. Furthermore, dydrogesterone is non-androgenic, non-estrogenic, non-corticoid, non-anabolic and is not excreted as pregnanediol. Dydrogesterone helps to regulate the healthy growth and normal shedding of the uterus lining. Therefore, it may be useful in the treatment of menstrual disorders such as absent, irregular or painful menstrual periods, infertility, premenstrual syndrome and endometriosis.

Abreva Absorption

Rapidly absorbed in the gastrointestinal tract.

Abreva side effects and Toxicity

No information avaliable

Abreva Patient Information

No information avaliable

Abreva Organisms Affected

Humans and other mammals